ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

AJVS. 2019; 63(1): 59-68


Some Toxicological, Hematological, Biochemical, and Reproductive Effects of Berberine In Male Rats

Abd El-Salam F. El-sawy, Zeynab Kh. El-Maddawy, Maha El Demellawy, Shaimaa M. Khedr.



Abstract
Download PDF Post

The present study was conducted to estimate the possible adverse effects of Berberine on biochemical, hematological, reproductive parameters in male rats. Thirty mature rats were divided into 2 groups. The first group (control) consists of 5 rats were administered Polyethyleneglycol 20% (PEG) at a dose level of 2ml/kg. B.wt. I/M. daily for 2 weeks. The second group consists of 25 rats were administered with Berberine 46mg/kg. B.wt. I/M. dissolved in PEG 20% daily for 2 weeks. The results showed that administration of Berberine induced a significant (P ≤ 0.05) reduction in Triglycerides, total cholesterol, and LDL-cholesterol. While, it induced a significant (P ≤ 0.05) increase in glutathione-s-transferase (GST), bilirubin level. While it induced a non-significant change in alanine aminotransferase(ALT), aspartate aminotransferase (AST), total protein, albumin, globulin, malondialdehyde (MDA), red blood corpuscles count (R.B.Cs), white blood corpuscle count (W.B.Cs), packed cell volume (PCV%), urea and creatinine. It showed an androgenic activity as it induced a significant (P ≤ 0.05) increase in sperm count, testosterone level. It could be concluded that Berberine is safe and consider a hepato-renal protective drug.

Key words: Berberine, adverse effects, hepato-renal, fertility.







Bibliomed Article Statistics

30
40
43
44
41
30
20
32
23
30
40
35
R
E
A
D
S

7

16

12

12

23

14

9

13

9

18

16

24
D
O
W
N
L
O
A
D
S
030405060708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.